• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CareDash Lands $2M for Online Doctor Rating & Review Platform

by Fred Pennic 02/09/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

CareDash

CareDash.com, an online doctor review and rating portal has secured nearly $1 million in venture debt financing and an additional $1 million line of credit led by Link Ventures, a Cambridge-based investment firm focused on internet and technology companies. With this new investment, the Cambridge, MA-based company plans to increase consumer awareness of the brand as a resource dedicated to transparency in the doctor review industry with a steadfast promise to reject payments from doctors seeking to remove and hide negative reviews, a widely-used industry practice.

Launched in 2016, CareDash makes doctor and hospital information more accessible, inclusive and transparent. Provider ratings and patient reviews on CareDash make it easy for consumers to make informed decisions about their health. Simply search for doctors by name, specialty or location, then review a list of providers who meet your search criteria.

Unlike other doctor review sites, CareDash does not influence, suppress or remove negative reviews in exchange for payment from providers. Unbeknownst to patients, existing doctor review sites accept payments from doctors to remove and hide negative reviews. CareDash also services more patients in the low-to-middle income range than leading patient review sites – many of whom have traditionally been ignored and underrepresented in this space.

“We started CareDash with the mission to arm patients with the transparent information they need to take charge of their healthcare,” said Ted Chan, founder and CEO, CareDash.com. “It’s one thing to eat a bad meal at a restaurant because a review was suppressed in exchange for compensation; it’s quite another to manipulate the healthcare information available to patients.” This latest round of funding from Link Ventures builds upon an exceptional year for CareDash which saw exponential growth of ratings and reviews, in addition to several key executive appointments. Link Ventures’ focus on market intelligence and corporate services will enable CareDash to continue improving the patient healthcare experience.”

CareDash currently features more than 30,000 reviews and ratings. The company generated $6.7 million in revenue in 2016 and previously raised $500,000 in seed capital.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: CareDash

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |